Company intelligence / Profile preview

BlueWind Medical

Park City, Utah, United Statesbluewindmedical.com ↗

Ownership: Private
Development stage: Commercial

Overview

The Revi™ implantable tibial neuromodulation device has demonstrated high patient satisfaction and significant reduction in urgent bladder leaks. In the OASIS Clinical Study, nearly 8 out of 10 participants experienced substantial reduction in leaks after two years; 97% reported satisfaction with therapy.

Therapeutic areas: NephrologyUrology
Modalities: DeviceNeuromodulation device
Industry: Implantable Medical Devices

Drug pipeline

1 asset

Revi

Commercial

Indications: Urge urinary incontinence, Overactive bladder

Beyond the preview

Go deeper on BlueWind Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BlueWind Medical.

Explore the full profile